Estun, China's Leading Industrial Robot Maker, Seeks Hong Kong IPO with RMB 3.8 Billion Revenue but Net Profit of Just RMB 25.37 Million

ZC Asia has learned that Estun (002747.SZ), a leading domestic industrial robot manufacturer, is advancing to the final stage of its H-share listing. The company commenced its public offering from February 27 to March 4 and is expected to officially list on the Hong Kong Stock Exchange on March 9. For this H-share offering, Estun plans to globally issue 96.78 million H-shares, with 10% allocated to the Hong Kong offering and 90% to the international offering. The offering price range is set at HK$15.36 to HK$17.00 per share. Each lot consists of 200 shares, with an entry cost of approximately HK$3,434.29 per lot.

Notably, the company has secured seven cornerstone investors who collectively committed US$66.91 million, including Harvest Oriental, Hengtong Photonics International, Haitian Huayuan, and Qianhai Hezhong Investment.

According to Frost & Sullivan data, Estun has maintained its position as China's top domestic industrial robotics solutions provider by shipment volume for multiple consecutive years. In the first half of 2025, the company achieved a historic breakthrough in the domestic market, surpassing foreign brands in industrial robot shipments to become the first domestic robotics enterprise to top the Chinese market.

Based on 2024 revenue, Estun ranked sixth among all manufacturers globally and in China, with market shares of 1.7% and 2.0%, respectively. The company primarily provides industrial robots, intelligent manufacturing systems, core automation components, and motion control systems to clients in sectors including automotive, construction machinery, heavy industry, and lithium batteries.

Although Estun attributes its core motivation for listing on the Hong Kong Stock Exchange to its global strategic layout, the market widely believes the more immediate drivers are alleviating financial crises and optimizing its capital structure.

Prospectus data reveals that as of September 2025, Estun's total assets reached RMB 10.133 billion, while total liabilities soared to RMB 8.15 billion. Its debt-to-asset ratio surged to 80.54%, far exceeding the industry average of 30%-50% for industrial robotics. This figure has climbed steadily from 69.1% in 2022 and now nearly doubles the industry's warning threshold.

More concerning is its short-term debt pressure. By the end of Q3 2025, the company held RMB 2.812 billion in short-term bank loans and over RMB 6.3 billion in non-current liabilities maturing within one year, while its cash and cash equivalents stood at only RMB 1.122 billion—revealing a massive funding gap. The company's current ratio of 0.97 and quick ratio of 0.73 both fell below the 1 safety threshold, indicating that liquid assets can no longer cover short-term debts.

Estun has built a full industrial chain spanning controllers, servo systems, and robot bodies through “internal R&D + external M&A,” acquiring companies including Germany's Prex, UK's Trio, Germany's Cloos, and Yangzhou Shuguang. However, aggressive acquisitions have also sown massive goodwill risks for the company.

In 2024, Estun's performance suffered a major setback. Net profit attributable to shareholders turned from profit to loss, plunging by 710% year-on-year to a massive deficit of 818 million yuan. A key driver of this loss was the 345 million yuan goodwill impairment charge for four subsidiaries—Prex, Trio Motion, Carl Cloos, and Yangzhou Shuguang—alongside 120 million yuan in combined impairment charges for accounts receivable, inventory, and intangible assets.

More alarmingly, even after booking these substantial impairments, the company's book goodwill remained as high as RMB 1.045 billion as of September 2025, accounting for over 50% of net assets. The goodwill associated with Germany's Cloos alone reached RMB 857 million, representing 82% of total goodwill. Should overseas subsidiaries continue to underperform expectations, Estun remains exposed to the risk of incurring further significant impairment charges.

Beyond this one-time massive loss, Estun's core business profitability also shows signs of weakness.

During the reporting period (2022 to the first nine months of 2025), the company's gross profit margin declined annually from 32.9% to 28.2%, a cumulative decrease of nearly 5 percentage points. For a leading enterprise touting “full industrial chain self-development and over 85% self-sufficiency in core components,” this sustained margin erosion exposes dual pressures: industry-wide price wars and ineffective cost control.

Meanwhile, the company's period expenses have consistently hovered around 28%, roughly matching its gross profit margin. This indicates that gross profit is nearly entirely consumed by R&D, sales, and administrative expenses. In the first three quarters of 2025, the company's net profit attributable to shareholders was only RMB 25.372 million, severely mismatched with its revenue of RMB 3.804 billion. After excluding non-recurring gains and losses, the company's projected net profit for 2025 is estimated at just RMB 6 to 8 million, revealing the fragile actual “blood-building” capacity of its core business.

Additionally, customer concentration surged sharply during the reporting period. Data shows the revenue share from the top five customers jumped from 16.4% in 2022 to 37.2% in the first three quarters of 2025, a 126.8% increase. The largest customer's revenue contribution soared from 5.5% to 18%, with the top two customers collectively accounting for 31.4% of total revenue. For the industrial robotics sector, which should inherently feature diversified client bases, this shift indicates a sharp increase in the company's reliance on major clients. Fluctuations in orders from any single client could trigger significant performance volatility.

Regarding equity structure, Estun exhibits distinct characteristics of family control. The prospectus reveals that the controlling shareholders are the couple Wu Bo and Liu Fang, along with their son Wu Kan. Through a combination of direct holdings and indirect control, the three collectively command 42.15% of the company's voting rights.

Estun's push for a Hong Kong listing represents both a strategic move in its global expansion and a crucial “blood transfusion” to address its high debt and capital hunger. Despite its reputation as China's leading domestic robotics manufacturer and backing from industrial capital, the company's management faces significant challenges post-funding: addressing the “hidden risks” of substantial goodwill, improving persistently declining gross margins, and reducing excessive reliance on major clients.

Disclaimer: The content herein is for reference only and does not constitute any form of investment advice. Should any information contained herein prove inaccurate, incomplete, or potentially misleading, please refer to the company's official announcements. Market risks exist; investment requires caution.